These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19345264)

  • 1. Human transplant acceptance-inducing cells suppress mitogen-stimulated T cell proliferation.
    Riquelme P; Gövert F; Geissler EK; Fändrich F; Hutchinson JA
    Transpl Immunol; 2009 Jul; 21(3):162-5. PubMed ID: 19345264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cell-based approach to the minimization of immunosuppression in renal transplantation.
    Hutchinson JA; Brem-Exner BG; Riquelme P; Roelen D; Schulze M; Ivens K; Grabensee B; Witzke O; Philipp T; Renders L; Humpe A; Sotnikova A; Matthäi M; Heumann A; Gövert F; Schulte T; Kabelitz D; Claas FH; Geissler EK; Kunzendorf U; Fändrich F
    Transpl Int; 2008 Aug; 21(8):742-54. PubMed ID: 18573141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15.
    Bocelli-Tyndall C; Bracci L; Schaeren S; Feder-Mengus C; Barbero A; Tyndall A; Spagnoli GC
    Ann Rheum Dis; 2009 Aug; 68(8):1352-9. PubMed ID: 18647856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.
    Ramasamy R; Tong CK; Seow HF; Vidyadaran S; Dazzi F
    Cell Immunol; 2008 Feb; 251(2):131-6. PubMed ID: 18502411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplant acceptance-inducing cells as an immune-conditioning therapy in renal transplantation.
    Hutchinson JA; Riquelme P; Brem-Exner BG; Schulze M; Matthäi M; Renders L; Kunzendorf U; Geissler EK; Fändrich F
    Transpl Int; 2008 Aug; 21(8):728-41. PubMed ID: 18573142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymers.
    Borges O; Borchard G; de Sousa A; Junginger HE; Cordeiro-da-Silva A
    Int J Pharm; 2007 Jun; 337(1-2):254-64. PubMed ID: 17317051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sub-mitogenic phorbol myristate acetate co-stimulation rescues the PHA-induced activation of both naïve and memory T cells cultured in the rotating-wall vessel bioreactor.
    Simons DM; Gardner EM; Lelkes PI
    Cell Biol Int; 2009 Aug; 33(8):882-6. PubMed ID: 19439187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral tolerance in CD8+ T cells.
    Srinivasan M; Frauwirth KA
    Cytokine; 2009 May; 46(2):147-59. PubMed ID: 19268604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogenic properties of Ukrain (NSC-6315170) on human peripheral blood monocytes: clinical implications.
    Jin YM; Nowicky JW; Liepins A
    Drugs Exp Clin Res; 1996; 22(3-5):99-101. PubMed ID: 8899311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation.
    MacMillan HF; Lee T; Issekutz AC
    Clin Immunol; 2009 Aug; 132(2):222-33. PubMed ID: 19447680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory properties of polysaccharopeptide derived from Coriolus versicolor and its combined effect with ciclosporin on the homeostasis of human lymphocytes.
    Lee CL; Jiang P; Sit WH; Yang X; Wan JM
    J Pharm Pharmacol; 2010 Aug; 62(8):1028-36. PubMed ID: 20663037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The indoor air pollutant 2-ethyl-hexanol activates CD4 cells.
    Yoshida Y; Liu J; Sugiura T; Ishidao T; Ueno S; Yanagita H; Fueta Y; Kunugita N; Hori H; Yamashita U
    Chem Biol Interact; 2009 Jan; 177(2):137-41. PubMed ID: 19038237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezetimibe and atorvastatin both immunoregulate CD4+ T cells from cardiac transplant recipients invitro.
    Shaw SM; Najam O; Khan U; Yonan N; Williams SG; Fildes JE
    Transpl Immunol; 2009 Jul; 21(3):179-82. PubMed ID: 19332119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief report--human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes.
    Yen BL; Chang CJ; Liu KJ; Chen YC; Hu HI; Bai CH; Yen ML
    Stem Cells; 2009 Feb; 27(2):451-6. PubMed ID: 18988708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells.
    Zheng J; Liu Y; Qin G; Chan PL; Mao H; Lam KT; Lewis DB; Lau YL; Tu W
    J Immunol; 2009 Sep; 183(6):3742-50. PubMed ID: 19684082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
    Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired lymphocyte responses and their restoration in oral cancer patients expressing distinct TCR variable region.
    Wadia P; Rao D; Pradhan T; Pathak A; Chiplunkar S
    Cancer Invest; 2008 Jun; 26(5):471-80. PubMed ID: 18568769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.
    Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T
    J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein.
    Mukai T; Maeda Y; Tamura T; Matsuoka M; Tsukamoto Y; Makino M
    J Immunol; 2009 Nov; 183(10):6561-8. PubMed ID: 19846882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.